Ignite Creation Date:
2025-12-24 @ 10:57 PM
Ignite Modification Date:
2026-01-02 @ 12:01 AM
Study NCT ID:
NCT02540369
Status:
COMPLETED
Last Update Posted:
2019-02-15
First Post:
2015-08-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
To Describe the Use of Intravitreal Aflibercept and to Describe Follow-up as Well as Treatment Patterns in Patients With Wet Age-related Macular Degeneration (wAMD) or Diabetic Macular Edema (DME) in Routine Clinical Practice in Canada.
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-12-14
Start Date Type:
ACTUAL
Primary Completion Date:
2017-09-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-01-26
Completion Date Type:
ACTUAL
First Submit Date:
2015-08-05
First Submit QC Date:
None
Study First Post Date:
2015-09-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-02-14
Last Update Post Date:
2019-02-15
Last Update Post Date Type:
ACTUAL